| Date |
Title |
| Dec 19, 2017 |
Illumina to Webcast Upcoming Investor Conference Presentations |
| Dec 11, 2017 |
Illumina Names Aimee Hoyt Chief People Officer, Bringing 20+ Years of
Senior Human Resources Leadership from Global Technology Companies |
| Nov 29, 2017 |
Illumina Opens First Commercial and Customer Training Center in France |
| Nov 22, 2017 |
Illumina to Webcast Upcoming Investor Conference Presentation |
| Nov 21, 2017 |
Illumina Wins Infringement Suit Against Premaitha Health plc and Ariosa
Diagnostics, Inc. |
| Nov 15, 2017 |
Illumina Grows Clinical IVD Portfolio with Introduction of NextSeq™
550Dx System and Expanded Use of MiSeq™Dx System |
| Nov 8, 2017 |
Illumina Names Gary S. Guthart, Ph.D., to its Board of Directors, Adding
Decades of Leadership Experience in Healthcare |
| Oct 24, 2017 |
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2017 |
| Oct 16, 2017 |
Illumina Releases NovaSeq S4 Flow Cell and NovaSeq Xp Workflow |
| Oct 10, 2017 |
Illumina to Announce Third Quarter 2017 Financial Results on Tuesday,
October 24, 2017 |
| Sep 7, 2017 |
Illumina Files New Patent Infringement Suit Against Premaitha Health plc |
| Aug 24, 2017 |
Illumina and Telegraph Hill Partners Launch Verogen, Inc. to Drive
Adoption of Next-Generation Sequencing in the Global Forensic Genomics Market |
| Aug 1, 2017 |
Illumina Reports Strong Financial Results for Second Quarter of Fiscal
Year 2017 |
| Jul 11, 2017 |
Illumina to Announce Second Quarter 2017 Financial Results on Tuesday,
August 1, 2017 |
| Jun 29, 2017 |
Illumina Announces FDA-approved Next-Generation Sequencing Cancer
Companion Diagnostic Test Kit |
| Jun 26, 2017 |
Genomics England Adopts Illumina’s BaseSpace Variant Interpreter for Cancer |
| May 30, 2017 |
Illumina to Webcast Live Presentation at the Goldman Sachs Global
Healthcare Conference |
| May 22, 2017 |
Illumina Names Mark Van Oene Chief Commercial Officer, Sales Leader
Brings Genomics Expertise and Strong Commercial Leadership Experience to
the Role |
| May 4, 2017 |
Illumina to Webcast Live Presentation at the Bank of America Merrill
Lynch Health Care Conference |
| Apr 25, 2017 |
Illumina Reports Financial Results for First Quarter of Fiscal Year 2017 |
| Apr 11, 2017 |
Illumina to Announce First Quarter 2017 Financial Results on Tuesday,
April 25, 2017 |
| Apr 10, 2017 |
Illumina Launches the VeriSeq™ NIPT Solution in Europe |
| Apr 3, 2017 |
Illumina Advances the Use of Genomics in Precision Oncology, Donates
Thousands of Somatic Interpretations to CIViC |
| Feb 28, 2017 |
Illumina Announces the iHope Network, an Expansion of Its iHope
Philanthropic Clinical Whole Genome Sequencing Program |
| Feb 21, 2017 |
Illumina to Webcast Live Presentation at the Cowen and Company Annual
Health Care Conference |
| Feb 20, 2017 |
Illumina Names John W. Thompson to Its Board of Directors, Bringing More
Than 40 Years of Technology Leadership to Illumina |
| Jan 31, 2017 |
Illumina Reports Full Financial Results for Fourth Quarter and Fiscal
Year 2016 |
| Jan 30, 2017 |
Illumina Debuts VeriSeq™ Analysis Software (48 Samples), Optimized Data
Analysis for Noninvasive Prenatal Testing |
| Jan 27, 2017 |
Illumina Names Caroline Dorsa to Its Board of Directors, Adding Over 30
Years of Leadership Experience in the Healthcare, Telecommunications and
Energy Industries |
| Jan 17, 2017 |
Illumina to Announce Fourth Quarter and Fiscal Year 2016 Financial
Results on Tuesday, January 31, 2017 |
| Jan 12, 2017 |
Illumina, NRGene Collaborate to Accelerate Development of New Molecular
Breeding Tools for Cattle to Support Global Food Production |
| Jan 9, 2017 |
Illumina and Bio-Rad Launch Solution for Single-Cell Genomic Sequencing
to Enable Robust Study of Complex Diseases |
| Jan 9, 2017 |
Philips and Illumina join forces to offer integrated genomics solutions
for oncology |
| Jan 9, 2017 |
Illumina Introduces the NovaSeq Series—a New Architecture Designed to
Usher in the $100 Genome |
| Jan 9, 2017 |
IBM and Illumina Partner to Standardize Genomic Data Interpretation |
| Jan 5, 2017 |
GRAIL Plans to Raise in Excess of $1B in Series B Funding |
| Jan 3, 2017 |
Illumina Taps Garret Hampton, One of the World’s Leading Clinical
Genomics Experts, to Head its Clinical Genomics Unit |